drugset / Trial / NCT02368431

Effectiveness of Zonisamide in Alcohol Dependent Veterans

NCT02368431

Phase 3 Terminated 92 enrolled VA Office of Research and Development
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized, placebo-controlled, double-blind, 16 week trial of the medication zonisamide for the treatment of heavy drinking alcoholic Veterans.

Timeline

Start
2015-03-01
Primary completion
2018-10-01
Completion
2018-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Zonisamide Other / unclassified 500 mg Oral
Subject Zonisamide Other / unclassified 600 mg Oral